Bank of America’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-31,611
Closed -$1.89M 7364
2020
Q2
$1.89M Buy
31,611
+4,571
+17% +$282K ﹤0.01% 3670
2020
Q1
$1.6M Buy
27,040
+6,917
+34% +$403K ﹤0.01% 3650
2019
Q4
$1.1M Buy
20,123
+9,656
+92% +$361K ﹤0.01% 4431
2019
Q3
$296K Sell
10,467
-1,798
-15% -$65.9K ﹤0.01% 5421
2019
Q2
$408K Sell
12,265
-315,694
-96% -$9.86M ﹤0.01% 5201
2019
Q1
$11.2M Buy
327,959
+325,450
+12,971% +$10.4M ﹤0.01% 2370
2018
Q4
$69K Buy
2,509
+2,353
+1,508% +$60.6K ﹤0.01% 6092
2018
Q3
$5K Buy
+156
New +$4.4K ﹤0.01% 6849

Other funds holding PRNB

Bank of America's PRNB Position: Q3 2020 in Review

Bank of America sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 31,611 shares — an estimated $1.89M sold.

Bank of America first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $11.2M in Q1 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Bank of America reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Bank of America sold 31,611 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.89M.
  • Bank of America first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Bank of America's Principia Biopharma Inc. Common Stock position peaked at $11.2M in Q1 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.